Back to search

Article

Identification of IGF2BP2 as a Prognostic Biomarker and Immunotherapeutic Target Based on Alternative Splicing Events in Glioblastoma

2021-09-21

Abstract excerpt

<title>Abstract</title> <p><bold>Aim:</bold> A glioblastoma (GBM) prognostic model was developed with GBM -related alternative splicing (AS) data and prognostic markers were identified. <bold>Methods:</bold> AS data and clinical data of GBM patients were retrieved from The Cancer Genome Atlas (TCGA) SpliceSeq database and TCGA database, respectively. The data from these two databases were intersected to screen th...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
45f48a3b-917c-5242-8908-cf6b0168bd1e
DOI
10.21203/rs.3.rs-900457/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Identification of IGF2BP2 as a Prognostic Biomarker and Immunotherapeutic Target Based on Alternative Splicing Events in GlioblastomaDOI 10.21203/rs.3.rs-900457/v1
Select a neighboring publication to make it the new centre.